NCT04598958

Brief Summary

This study aims to improve maternal and child health (MCH) outcomes by implementing and evaluating a multidisciplinary "Integrated Management Team to Improve Maternal-Child Outcomes (IMPROVE)" intervention to increase MCH, antiretroviral therapy (ART), and HIV services uptake and retention in Lesotho. The proposed intervention will focus efforts to improve the effectiveness of existing village health workers (VHW) and HIV support organizations (Lesotho Network of AIDS Service Organizations \[LENASO\] and Mothers2Mothers \[M2M\]) based at the facility and coordination between the facility and community. The IMPROVE intervention includes: (1) Multidisciplinary integrated management teams to coordinate patient-focused and outcome-oriented PMTCT and MCH services; (2) Enhanced Positive Health, Dignity, and Prevention (PHDP)-focused counseling and skills-building training and job aids; and (3) Increased early community-based counseling and support for first (antenatal care clinic) ANC attendees with particular attention to HIV-positive women to minimize loss to follow-up. The study will be a cluster randomized design with facilities randomized to receive the IMPROVE intervention or routine services offering the national standard of care. A cohort of HIV-positive and HIV-negative pregnant women will be enrolled and prospectively followed every three months through pregnancy and until the participant's child reaches 24 months of age. The primary HIV objectives will be to evaluate the effect of the intervention on retention in HIV care, viral suppression, adherence to ART in HIV-positive women, and HIV retesting in HIV-negative women. The investigators will also assess the effect of the IMPROVE intervention on general MCH indices including antenatal care (ANC) attendance, facility delivery, family planning, and immunization coverage. Secondary objectives include evaluation of adherence self-efficacy (HIV positive) or prevention self-efficacy (HIV negative), depression and stigma as well as disclosure, knowledge of partner status, and identification of discordant couples in intervention versus control facilities. Analysis of the cost-effectiveness of the IMPROVE intervention will also be conducted. In addition, qualitative interviews and focus group discussions will be conducted with study women, health care workers (HCW), LENASO, and VHWs to evaluate the feasibility and acceptability of integrating this intervention into routine care.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,004

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jul 2016

Longer than P75 for not_applicable

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 27, 2016

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2019

Completed
1.2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2020

Completed
5 days until next milestone

First Submitted

Initial submission to the registry

October 5, 2020

Completed
17 days until next milestone

First Posted

Study publicly available on registry

October 22, 2020

Completed
Last Updated

October 22, 2020

Status Verified

October 1, 2020

Enrollment Period

3 years

First QC Date

October 5, 2020

Last Update Submit

October 19, 2020

Conditions

Keywords

maternal child healthprevention of mother to child transmissionHIV

Outcome Measures

Primary Outcomes (5)

  • Retention

    Proportion of participants retained in care

    at 24 months post partum

  • ART Adherence

    Proportion of HIV-positive women on treatment with \>95% adherence based on effective pill count

    at 24 months postpartum

  • Viral suppression rate

    Proportion of HIV-positive women with undetectable viral load

    at 24 months postpartum

  • HIV retesting rate

    Proportion of HIV-negative women who received additional HIV testing

    at 24 months postpartum

  • Targeted MCH health seeking behaviors

    Proportion of women who delivered at a health facility

    At 24 months postpartum

Secondary Outcomes (4)

  • General MCH Outcomes

    24 months postpartum

  • HIV outcomes

    at 6 weeks of infant age

  • Depression

    at enrollment

  • Cost-effectiveness of implementing the IMPROVE intervention

    At 24 months postpartum

Study Arms (2)

IMPROVE

EXPERIMENTAL

A cluster of 6 health facilities are to receive the IMPROVE Intervention. The IMPROVE intervention includes: (1) Multidisciplinary integrated management teams to coordinate patient-focused and outcome-oriented PMTCT and MCH services; (2) Enhanced Positive Health, Dignity, and Prevention (PHDP)-focused counseling and skills-building training and job aids; and (3) Increased early community-based counseling and support for first (antenatal care clinic) ANC attendees with particular attention to HIV-positive women to minimize loss to follow-up.

Other: IMPROVE

Standard of care

NO INTERVENTION

A cluster of 6 health facilities receive Standard of Care. Routine health facility services offering the national standard of care for pregnant and breastfeeding women in Lesotho

Interventions

IMPROVEOTHER

Health system interventions that include: (1) Multidisciplinary integrated management teams to coordinate patient-focused and outcome-oriented PMTCT and MCH services; (2) Enhanced Positive Health, Dignity, and Prevention (PHDP)-focused counseling and skills-building training and job aids; and (3) Increased early community-based counseling and support for first (antenatal care clinic) ANC attendees

IMPROVE

Eligibility Criteria

Sexfemale
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Pregnant woman attending first ANC visit at a study facility . There is no age restriction for study enrollment as young pregnant women in Lesotho are consider emancipated.
  • HIV status known at time of enrollment
  • Residing in an area around a study facility
  • Willing and able to provide informed consent

You may not qualify if:

  • Pregnant women attending 2nd or later ANC visits
  • Attending care at study facility temporarily
  • Significant medical or psychological condition that would preclude active study participation
  • Inability to provide informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Beres LK, Chabela M, Masitha M, Catanzarite Z, Tukei VJ, Mofenson L, Tiam A, Greenberg L, Mokone M, Thabelo R, Nchephe M, Mots'oane T, Guay L, Knowlton AR. An integrated, multidisciplinary management team intervention to improve patient-centeredness, HIV, and maternal-child outcomes in Lesotho: formative research on participatory implementation strategies. BMC Health Serv Res. 2024 Dec 18;24(1):1590. doi: 10.1186/s12913-024-12049-x.

MeSH Terms

Conditions

Acquired Immunodeficiency Syndrome

Condition Hierarchy (Ancestors)

HIV InfectionsBlood-Borne InfectionsCommunicable DiseasesInfectionsSexually Transmitted Diseases, ViralSexually Transmitted DiseasesLentivirus InfectionsRetroviridae InfectionsRNA Virus InfectionsVirus DiseasesSlow Virus DiseasesGenital DiseasesUrogenital DiseasesImmunologic Deficiency SyndromesImmune System Diseases

Study Officials

  • Appolinaire Tiam, MD

    Elizabeth Glaser Pediatric AIDS Foundation

    PRINCIPAL INVESTIGATOR
  • Laura A Guay, MD

    Elizabeth Glaser Pediatric AIDS Foundation

    PRINCIPAL INVESTIGATOR
  • Lynne Mofenson, MD

    Elizabeth Glaser Pediatric AIDS Foundation

    PRINCIPAL INVESTIGATOR
  • Vincent Tukei, MD

    Elizabeth Glaser Pediatric AIDS Foundation

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: This is a cluster randomized design. Two clusters of health facilities were randomized to receive either the intervention or standard of care. There are 6 facilities in each cluster. Individual participants are treated based on the cluster they fall into
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 5, 2020

First Posted

October 22, 2020

Study Start

July 27, 2016

Primary Completion

July 31, 2019

Study Completion

September 30, 2020

Last Updated

October 22, 2020

Record last verified: 2020-10

Data Sharing

IPD Sharing
Will not share

The dataset generated and used for this analysis is available from the study biostatistician (hhoffman@gwu.edu) on reasonable request